Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 4:39 pm Unchanged | 2021-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | BB BIOTECH AG | 4,477,964 7.100% | 0 (Unchanged) | Filing History |
| 2022-02-11 4:09 pm Unchanged | 2021-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | Deerfield Mgmt, L.P. | 10,000,000 8.060% | 0 (Unchanged) | Filing History |
| 2022-02-11 2:54 pm Purchase | 2022-02-11 | 13G | Esperion Therapeutics, Inc. ESPR | Wasatch Advisors LP | 9,339,046 14.400% | 5,341,036 (+133.59%) | Filing History |
| 2022-02-10 08:11 am Purchase | 2021-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | The Vanguard Group | 3,761,439 6.060% | 1,396,132 (+59.03%) | Filing History |
| 2022-02-09 1:02 pm Sale | 2021-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | STATE STREET CORP STT | 1,046,377 1.690% | -1,476,167 (-58.52%) | Filing History |
| 2022-01-12 2:15 pm Purchase | 2021-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | Meditor Group Ltd | 4,468,835 7.100% | 1,789,000 (+66.76%) | Filing History |
| 2022-01-10 12:54 pm Purchase | 2021-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | BlackRock Inc. BLK | 2,241,217 3.600% | 177,012 (+8.58%) | Filing History |
| 2022-01-04 9:16 pm Sale | 2021-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | SABBY MANAGEMENT LLC | 3,095,410 11.000% | -2,618,876 (-45.83%) | Filing History |
| 2021-12-10 12:18 pm Purchase | 2021-12-02 | 13G | Esperion Therapeutics, Inc. ESPR | CVI Investments, Inc. | 6,274,385 9.900% | 6,274,385 (New Position) | Filing History |
| 2021-12-09 4:54 pm Purchase | 2021-12-03 | 13G | Esperion Therapeutics, Inc. ESPR | Deep Track Capital, LP | 6,345,790 9.990% | 6,345,790 (New Position) | Filing History |
| 2021-12-09 10:11 am Purchase | 2021-12-03 | 13G | Esperion Therapeutics, Inc. ESPR | SABBY MANAGEMENT LLC | 5,714,286 11.000% | 5,714,286 (New Position) | Filing History |
| 2021-12-07 5:19 pm Purchase | 2021-12-07 | 13G | Esperion Therapeutics, Inc. ESPR | Deerfield Mgmt, L.P. | 10,000,000 8.170% | 10,000,000 (New Position) | Filing History |
| 2021-05-28 5:00 pm Purchase | 2021-05-19 | 13G | Esperion Therapeutics, Inc. ESPR | BB BIOTECH AG | 4,477,964 15.900% | 530,000 (+13.42%) | Filing History |
| 2021-02-16 4:42 pm Sale | 2020-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | Pentwater Capital Management LP | 722,580 2.590% | -1,545,681 (-68.14%) | Filing History |
| 2021-02-16 09:56 am Sale | 2020-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | MARSHALL WACE, LLP | 1,370,352 4.900% | -157,749 (-10.32%) | Filing History |
| 2021-02-12 4:58 pm Purchase | 2020-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | BB BIOTECH AG | 3,947,964 14.200% | 220,000 (+5.90%) | Filing History |
| 2021-02-11 7:45 pm Unchanged | 2021-02-11 | 13G | Esperion Therapeutics, Inc. ESPR | PLATINUM INVESTMENT MANAGEMENT LTD | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-02-11 1:03 pm Purchase | 2020-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | STATE STREET CORP STT | 2,522,544 9.050% | 1,421,035 (+129.01%) | Filing History |
| 2021-02-10 10:52 am Sale | 2020-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | The Vanguard Group | 2,365,307 8.480% | -282,604 (-10.67%) | Filing History |
| 2021-02-09 2:56 pm Purchase | 2021-02-09 | 13G | Esperion Therapeutics, Inc. ESPR | Wasatch Advisors LP | 3,998,010 14.300% | 161,567 (+4.21%) | Filing History |